The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Randomized, open-label, multicenter study to compare the efficacy and safety of combination
of Sitagliptin and danazol versus danazol for the treatment of adults with
steroid-resistant/relapse immune thrombocytopenia (ITP).